Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, presenting promising enhancements across various health care and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, additional responsible alternate for therapeutic